ARCHIVES

Letter To the Editor: Screening Revisited

This article is from The Cancer Letter archive.

Vol. 20 No. 20 | May 20, 1994

Download PDF Visit The Full Archive

Related Articles

Report Backs EPA Classification of PERC as Likely Human Carcinogen

February 12, 2010

Antibody Targeting PD-L1 Shows Fast Tumor Shrinkage

May 31, 2013

DCT Board Okays Extension Of Phase 1 Master Agreements, Increase To $4 Million

February 27, 1987

Also in this 12-page issue: NCI gives Doroshow and Fine “lead role” in clinical trials system review.

November 14, 2003

Flood Asks ACCC for Greater Community Effort

February 14, 1975

Zometa Better Than Placebo In Treatment Of Bone Mets

August 31, 2001